Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-26 @ 12:59 AM
NCT ID:
NCT01575834
Pre Assignment Details:
Participants were randomized 1:1 to receive either romosozumab 210 mg or matched placebo for the 12-month, double-blind, placebo-controlled period. Randomization was stratified by age (\< 75 years, ≥ 75 years) and prevalent vertebral fracture (yes, no), as determined by site staff at randomization based on local reading of the spine X-ray.
Recruitment Details:
This study was conducted at 222 centers in Europe, Central/Latin America, Asia, North America, and Australia/New Zealand.
The first participant enrolled on 15 March 2012 and the last participant enrolled on 06 December 2013.
Study:
NCT01575834
Study Brief:
Results Section:
NCT01575834